All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

121

Reset

121 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CagrilintidePhase 320 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • HRS-7535Phase 310 trials

    Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

  • INS1009Treprostinil PalmitilPhase 37 trials

    Insmed Incorporated · Interstitial Lung Disease, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • CagriSemaCagrilintide B and Semaglutide IPhase 36 trials

    Novo Nordisk · Obesity, Diabetes Mellitus, Type 2, Hypertension

  • Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials

    United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

  • lorundrostatPhase 35 trials

    Mineralys Therapeutics Inc. · Hypertension, Obstructive Sleep Apnea, Chronic Kidney Disease

  • VCT220CX11Phase 35 trials

    Vincentage Pharma Co., Ltd · Obesity, Type 2 Diabetes Mellitus (DM), Hypertension

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • ZilebesiranALN-AGT01Phase 34 trials

    Alnylam Pharmaceuticals · Hypertension, High Cardiovascular Risk, High Risk Cardiovascular Disease

  • SpyGlass Pharma, Inc. · Cataract, Glaucoma, Ocular Hypertension

  • HRS-1780Phase 33 trials

    Shandong Suncadia Medicine Co., Ltd. · Chronic Kidney Disease, Uncontrolled or Resistant Hypertension, Primary Aldosteronism

  • Timolol eye drops 0.5%Phase 33 trials

    Glaukos Corporation · Glaucoma, Ocular Hypertension

  • TNX-103Phase 33 trials

    Tenax Therapeutics, Inc. · Pulmonary Hypertension Associated With HFpEF, Pulmonary Hypertension

  • ClazakizumabLY5724886, CSL300Phase 32 trials

    Eli Lilly · Atherosclerosis, Cardiovascular Disease, Obesity

  • DWC202314Phase 32 trials

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension, Hypertension

  • DWC202314PPhase 32 trials

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension, Hypertension

  • Shenzhen Salubris Pharmaceuticals Co., Ltd. · Essential Hypertension

  • HCP1803-3Phase 32 trials

    Hanmi Pharmaceutical Company Limited · Hypertension

  • IKT-001Phase 32 trials

    Inhibikase Therapeutics · Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH)

  • Inactive controlQLS-111 vehiclePhase 32 trials

    Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)

  • MosliciguatPhase 32 trials

    Pulmovant, Inc. · Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases

  • NCX 470NCX 470 0.1%Phase 32 trials

    Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension

  • RalinepagAPD811Phase 32 trials

    United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • RLD2001-1Phase 32 trials

    Hanmi Pharmaceutical Company Limited · Hypertension

  • SAL0120Phase 32 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Chronic Kidney Disease, Uncontrolled Hypertension, Resistant Hypertension

  • SeralutinibPhase 32 trials

    Gossamer Bio USA, Inc. · Pulmonary Arterial Hypertension

  • AD-223APhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-223BPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-223CPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224APhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224BPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224CPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-227APhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-227BPhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-227CPhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • ATB-1011Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1012Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1013Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • BR1018APhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018BPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018CPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1019APhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019BPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019CPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

Page 1 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.